Hospital Arnau de Vilanova-ko ikertzaileekin lankidetzan egindako argitalpenak (35)

2024

  1. Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score

    Liver International, Vol. 44, Núm. 1, pp. 202-213

  2. Improved cognition after rifaximin treatment is associated with changes in intra- and inter-brain network functional connectivity

    Journal of Translational Medicine, Vol. 22, Núm. 1

2023

  1. Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  2. Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

  3. Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease

    Frontiers in Endocrinology, Vol. 14

2022

  1. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease

    Radiology, Vol. 302, Núm. 2, pp. 345-354

  2. Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications

    Histopathology, Vol. 81, Núm. 6, pp. 826-840

  3. Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy

    Scientific Reports, Vol. 12, Núm. 1

  4. Minimal hepatic encephalopathy is associated to alterations in eye movements

    Scientific reports, Vol. 12, Núm. 1, pp. 16837

  5. Plasma Extracellular Vesicles Play a Role in Immune System Modulation in Minimal Hepatic Encephalopathy

    International Journal of Molecular Sciences, Vol. 23, Núm. 20

2021

  1. A new score unveils a high prevalence of mild cognitive impairment in patients with nonalcoholic fatty liver disease

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  2. Digital pathology enables automated and quantitative assessment of inflammatory activity in patients with chronic liver disease

    Biomolecules, Vol. 11, Núm. 12

  3. Patients with minimal hepatic encephalopathy show altered thermal sensitivity and autonomic function

    Journal of Clinical Medicine, Vol. 10, Núm. 2, pp. 1-18

2020

  1. Hyperammonemia alters the mismatch negativity in the auditory evoked potential by altering functional connectivity and neurotransmission

    Journal of Neurochemistry, Vol. 154, Núm. 1, pp. 56-70

  2. Motor and cognitive performance in patients with liver cirrhosis with minimal hepatic encephalopathy

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-16

2019

  1. Meningioma-like Tumor of the Skin Revisited: A Distinct CD34+ Dermal Tumor with an Expanded Histologic Spectrum

    American Journal of Surgical Pathology, Vol. 43, Núm. 11, pp. 1518-1525

  2. Selective improvement by rifaximin of changes in the immunophenotype in patients who improve minimal hepatic encephalopathy

    Journal of Translational Medicine, Vol. 17, Núm. 1

2018

  1. Cirrhotic patients with minimal hepatic encephalopathy have increased capacity to eliminate superoxide and peroxynitrite in lymphocytes, associated with cognitive impairment

    Free Radical Research, Vol. 52, Núm. 1, pp. 118-133

  2. Soluble immune biomarkers to anti-PD1 treatment in non-small cell lung cancer (NSCLC)

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii512-viii513

2017

  1. Altered postural control and stability in cirrhotic patients with minimal hepatic encephalopathy correlate with cognitive deficits

    Liver International, Vol. 37, Núm. 7, pp. 1013-1022